Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Fiona Dunlevy"'
Autor:
Silke van Koningsbruggen-Rietschel, Fiona Dunlevy, Veerle Bulteel, Kate Hayes, Anne Verbrugge, Hettie M. Janssens, Nadine Dufeu, Nicholas J. Simmonds, Lieven J. Dupont, Damian G. Downey
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-7 (2021)
Abstract The SARS-CoV-2 pandemic has disrupted clinical trials worldwide. The European Cystic Fibrosis Society-Clinical Trials Network (ECFS-CTN) has tracked clinical trial disruption by surveying its 58 trial sites across 17 European countries and c
Externí odkaz:
https://doaj.org/article/2d2ad1ad0bd14edc96d2410f3d180aa4
Autor:
Anita Golec, Iwona Pranke, Paolo Scudieri, Kate Hayes, Elise Dreano, Fiona Dunlevy, Aurelie Hatton, Damian G. Downey, Luis Galietta, Isabelle Sermet
Publikováno v:
STAR Protocols, Vol 3, Iss 2, Pp 101419- (2022)
Summary: Here, we present a standardized protocol for isolation, maintenance, and polarization of the respiratory epithelial primary cells from patient samples acquired from nasal brushing, polyp specimens, or lung explants. This protocol generates a
Externí odkaz:
https://doaj.org/article/69a2664f7cd94d6dbe1740df2a2a3e6c
Autor:
Andreas Jung, Annalisa Orenti, Fiona Dunlevy, Elina Aleksejeva, Egil Bakkeheim, Vladimir Bobrovnichy, Siobhán B. Carr, Carla Colombo, Harriet Corvol, Rebecca Cosgriff, Géraldine Daneau, Deniz Dogru, Pavel Drevinek, Andrea Dugac Vukic, Isabelle Fajac, Alice Fox, Stojka Fustik, Vincent Gulmans, Satenik Harutyunyan, Elpis Hatziagorou, Irena Kasmi, Hana Kayserová, Elena Kondratyeva, Uroš Krivec, Halyna Makukh, Kestutis Malakauskas, Edward F. McKone, Meir Mei-Zahav, Isabelle de Monestrol, Hanne Vebert Olesen, Rita Padoan, Tsitsino Parulava, Maria Dolores Pastor-Vivero, Luísa Pereira, Guergana Petrova, Andreas Pfleger, Liviu Pop, Jacqui G. van Rens, Milan Rodic´, Marc Schlesser, Valérie Storms, Oxana Turcu, Lukasz Woz´niacki, Panayiotis Yiallouros, Anna Zolin, Damian G. Downey, Lutz Naehrlich
Publikováno v:
ERJ Open Research, Vol 7, Iss 4 (2021)
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in people with cystic fibrosis (pwCF) can lead to severe outcomes. Methods In this observational study, the European Cystic Fibrosis Society Patient Registry collected
Externí odkaz:
https://doaj.org/article/3e2becbd44ec4bf582d17021b6083a88
Autor:
Isabelle Fajac, Egil Bakkeheim, Halyna Makukh, Tsitsino Parulava, Jacqui G. van Rens, A. Fox, Luísa Pereira, A. Zolin, Hanne Vebert Olesen, Panayiotis K. Yiallouros, Damian G. Downey, Carla Colombo, Elpis Hatziagorou, Andreas Jung, Harriet Corvol, Pavel Drevinek, Liviu Pop, Elena Kondratyeva, Géraldine Daneau, Irena Kasmi, Siobhán B. Carr, Vincent Gulmans, Rebecca Cosgriff, Edward F. McKone, Lukasz Woźniacki, Satenik Harutyunyan, Andrea Dugac Vukic, Annalisa Orenti, Lutz Naehrlich, Rita Padoan, Deniz Dogru, Fiona Dunlevy, S. Fustik, Valérie Storms, Vladimir Bobrovnichy, Milan Rodić, Kęstutis Malakauskas, Meir Mei-Zahav, Marc Schlesser, Andreas Pfleger, Uros Krivec, Hana Kayserova, Oxana Turcu, María Dolores Pastor-Vivero, Guergana Petrova, Isabelle de Monestrol, Elina Aleksejeva
Publikováno v:
Jung, A, Orenti, A, Dunlevy, F, Aleksejeva, E, Bakkeheim, E, Bobrovnichy, V, Carr, S B, Colombo, C, Corvol, H, Cosgriff, R, Daneau, G, Dogru, D, Drevinek, P, Vukic, A D, Fajac, I, Fox, A, Fustik, S, Gulmans, V, Harutyunyan, S, Hatziagorou, E, Kasmi, I, Kayserová, H, Kondratyeva, E, Krivec, U, Makukh, H, Malakauskas, K, McKone, E F, Mei-Zahav, M, de Monestrol, I, Olesen, H V, Padoan, R, Parulava, T, Pastor-Vivero, M D, Pereira, L, Petrova, G, Pfleger, A, Pop, L, van Rens, J G, Rodic, M, Schlesser, M, Storms, V, Turcu, O, Woz Niacki, L, Yiallouros, P, Zolin, A, Downey, D G & Naehrlich, L 2021, ' Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe ', ERJ Open Research, vol. 7, no. 4, 00411 . https://doi.org/10.1183/23120541.00411-2021
ERJ Open Research, Vol 7, Iss 4 (2021)
Jung, A, Orenti, A, Dunlevy, F, Aleksejeva, E, Bakkeheim, E, Bobrovnichy, V, Carr, S B, Colombo, C, Corvol, H, Cosgriff, R, Daneau, G, Dogru, D, Drevinek, P, Vukic, A D, Fajac, I, Fox, A, Fustik, S, Gulmans, V, Harutyunyan, S, Hatziagorou, E, Kasmi, I, Kayserová, H, Kondratyeva, E, Krivec, U, Makukh, H, Malakauskas, K, McKone, E F, Mei-Zahav, M, de Monestrol, I, Olesen, H V, Padoan, R, Parulava, T, Pastor-Vivero, M D, Pereira, L, Petrova, G, Pfleger, A, Pop, L, van Rens, J G, Rodić, M, Schlesser, M, Storms, V, Turcu, O, Woźniacki, L, Yiallouros, P, Zolin, A, Downey, D G & Naehrlich, L 2021, ' Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe ', ERJ Open Research, vol. 7, no. 4, 00411-2021 . https://doi.org/10.1183/23120541.00411-2021
ERJ Open Research
article-version (AM) Accepted Manuscript
ERJ Open Research, Vol 7, Iss 4 (2021)
Jung, A, Orenti, A, Dunlevy, F, Aleksejeva, E, Bakkeheim, E, Bobrovnichy, V, Carr, S B, Colombo, C, Corvol, H, Cosgriff, R, Daneau, G, Dogru, D, Drevinek, P, Vukic, A D, Fajac, I, Fox, A, Fustik, S, Gulmans, V, Harutyunyan, S, Hatziagorou, E, Kasmi, I, Kayserová, H, Kondratyeva, E, Krivec, U, Makukh, H, Malakauskas, K, McKone, E F, Mei-Zahav, M, de Monestrol, I, Olesen, H V, Padoan, R, Parulava, T, Pastor-Vivero, M D, Pereira, L, Petrova, G, Pfleger, A, Pop, L, van Rens, J G, Rodić, M, Schlesser, M, Storms, V, Turcu, O, Woźniacki, L, Yiallouros, P, Zolin, A, Downey, D G & Naehrlich, L 2021, ' Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe ', ERJ Open Research, vol. 7, no. 4, 00411-2021 . https://doi.org/10.1183/23120541.00411-2021
ERJ Open Research
article-version (AM) Accepted Manuscript
BackgroundSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in people with cystic fibrosis (pwCF) can lead to severe outcomes.MethodsIn this observational study, the European Cystic Fibrosis Society Patient Registry collected dat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::392cf65c7443a8c40ebd833b2119920c
https://pure.qub.ac.uk/en/publications/948d660d-d10e-476b-8ddc-8f3928d49b2c
https://pure.qub.ac.uk/en/publications/948d660d-d10e-476b-8ddc-8f3928d49b2c
Autor:
Veerle Bulteel, Fiona Dunlevy, Hettie M. Janssens, Lieven Dupont, Nicholas J. Simmonds, Anne Verbrugge, Damian G. Downey, Silke van Koningsbruggen-Rietschel, Kate Hayes, Nadine Dufeu
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-7 (2021)
van Koningsbruggen-Rietschel, S, Dunlevy, F, Bulteel, V, Hayes, K, Verbrugge, A, Janssens, H M, Dufeu, N, Simmonds, N J, Dupont, L J & Downey, D G 2021, ' Protecting clinical trials in cystic fibrosis during the SARS-CoV-2 pandemic: risks and mitigation measures ', Trials, vol. 22, 578 . https://doi.org/10.1186/s13063-021-05457-5
Trials
Trials, 22(1):578. BioMed Central Ltd.
van Koningsbruggen-Rietschel, S, Dunlevy, F, Bulteel, V, Hayes, K, Verbrugge, A, Janssens, H M, Dufeu, N, Simmonds, N J, Dupont, L J & Downey, D G 2021, ' Protecting clinical trials in cystic fibrosis during the SARS-CoV-2 pandemic: risks and mitigation measures ', Trials, vol. 22, 578 . https://doi.org/10.1186/s13063-021-05457-5
Trials
Trials, 22(1):578. BioMed Central Ltd.
The SARS-CoV-2 pandemic has disrupted clinical trials worldwide. The European Cystic Fibrosis Society-Clinical Trials Network (ECFS-CTN) has tracked clinical trial disruption by surveying its 58 trial sites across 17 European countries and collated i
Autor:
Halyna Makukh, Andrea Dugac Vukic, Meir Mei-Zahav, Tsitsino Parulava, Harriet Corvol, Godfrey Fletcher, Rita Padoan, S. Fustik, Silke van Koningsbruggen-Rietschel, Fiona Dunlevy, Andreas Jung, Hana Kayserova, Satenik Harutyunyan, Siobhán B. Carr, Domenique Zomer-van Ommen, Łukasz Woźniacki, Svetlana Keegan, Elena Kondratyeva, Jacqui G. van Rens, Elpis Hatziagorou, Carla Colombo, Pedro Mondejar-Lopez, Vincent Gulmans, Anita Senstad Wathne, María Dolores Pastor-Vivero, Milan Macek, Egil Bakkeheim, Milan Rodić, Sevgi Pekcan, Filia Diamantea, Elliott McClenaghan, Géraldine Daneau, Guergana Petrova, Kęstutis Malakauskas, Marko Krasnyk, Yasemin Gokdemir, Panayiotis K. Yiallouros, Elise Lammertyn, Marc Schlesser, Edward F. McKone, Andreas Pfleger, Olga I. Simonova, Luísa Pereira, Elena Zhekaite, Anders Lindblad, Oxana Turcu, Andrea Párniczky, Isabelle de Monestrol, Duška Tješić-Drinković, Elina Aleksejeva, Uro Krivecs, Lutz Naehrlich, Elena Amelina, A. Zolin, Pierre-Régis Burgel, Vladimir Bobrovnichy, Annalisa Orenti, Alena Bilkova, Deniz Dogru, Liviu Pop, Marco Salvatore, Nataliya Kashirskaya, Irena Kasmi, Keith G. Brownlee, Pavel Drevinek, Hanne Vebert Olesen, Rebecca Cosgriff, Lydie Lemonnier-Videau, A. Fox, Ivan Bambir
Publikováno v:
Naehrlich, L, Orenti, A, Dunlevy, F, Kasmi, I, Harutyunyan, S, Pfleger, A, Keegan, S, Daneau, G, Petrova, G, Tješić-Drinković, D, Yiallouros, P, Bilkova, A, Olesen, H V, Burgel, P R, Parulava, T, Diamantea, F, Párniczky, A, McKone, E F, Mei-Zahav, M, Salvatore, M, Colombo, C, Aleksejeva, E, Malakauskas, K, Schlesser, M, Fustik, S, Turcu, O, Zomer-van Ommen, D, Wathne, A S, Woźniacki, Ł, Pereira, L, Pop, L, Kashirskaya, N, Rodić, M, Kayserova, H, Krivecs, U, Mondejar-Lopez, P, de Monestrol, I, Dogru, D, Makukh, H, Cosgriff, R, van Koningsbruggen-Rietschel, S, Jung, A & European Cystic Fibrosis COVID project group 2021, ' Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020 ', Journal of Cystic Fibrosis, vol. 20, no. 4, pp. 566-577 . https://doi.org/10.1016/j.jcf.2021.03.017
Journal of Cystic Fibrosis
Journal of Cystic Fibrosis
Background: Viral infections can cause significant morbidity in cystic fibrosis (CF). The current Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic could therefore have a serious impact on the health of people with CF (pwCF). Meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::890c3cc12ea4caf2f33deed43b74c782
https://pure.au.dk/ws/files/275030134/1_s2.0_S1569199321000990_main.pdf
https://pure.au.dk/ws/files/275030134/1_s2.0_S1569199321000990_main.pdf
Autor:
Veerle Bulteel, Kate Hayes, Damien G. Downey, Anne Verbrugge, Silke van Koningsbruggen-Rietschel, Hettie M. Janssens, Nicolas J. Simmonds, Lieven Dupont, Nadine Dufeu, Fiona Dunlevy
Publikováno v:
van Koningsbruggen-Rietschel, S, Dunlevy, F, Bulteel, V, Hayes, K, Verbrugge, A, Janssens, H, Dufeu, N, Simmonds, N J, Dupont, L J & Downey, D G 2021, ' Protecting Clinical Trials in Cystic Fibrosis; COVID-19 Mitigation Measures Crowd Sourced from the European Cystic Fibrosis Society Clinical Trials Network ', Trials, pp. 1 . https://doi.org/10.21203/rs.3.rs-297415/v1
The SARS-CoV-2 pandemic has disrupted clinical trials worldwide. The European Cystic Fibrosis Society-Clinical Trials Network (ECFS-CTN) has tracked clinical trial disruption by surveying its 58 trial sites across 17 European countries and collated i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::365b6e0a58e3e56aed35bf53ea88776d
https://doi.org/10.21203/rs.3.rs-297415/v1
https://doi.org/10.21203/rs.3.rs-297415/v1
European Cystic Fibrosis Society Clinical Trials Network (ECFS-CTN): structure and impact since 2009
Autor:
Isabelle Fajac, Paola de Carli, Veerle Bulteel, Damian G. Downey, Silke van Koningsbruggen-Rietschel, Kris De Boeck, Nick Simmonds, Kate Hayes, Lieven Dupont, Fiona Dunlevy, Tim W.R. Lee, Nadine Dufeu, Hettie M. Janssens, Isabelle Sermet-Gaudelus, Dorota Sands
Publikováno v:
Cystic fibrosis.
Autor:
Veerle Bulteel, Damian G. Downey, Fiona Dunlevy, Silke van Koningsbruggen-Rietschel, Lieven Dupont
Publikováno v:
The European Respiratory Journal
article-version (AM) Accepted Manuscript
van Koningsbruggen-Rietschel, S, Dunlevy, F, Bulteel, V, Downey, D & Dupont, L 2020, ' SARS-CoV2 disrupts clinical research-the role of a rare disease-specific trial network ', European Respiratory Journal, vol. 56, no. 3 . https://doi.org/10.1183/13993003.02114-2020
article-version (AM) Accepted Manuscript
van Koningsbruggen-Rietschel, S, Dunlevy, F, Bulteel, V, Downey, D & Dupont, L 2020, ' SARS-CoV2 disrupts clinical research-the role of a rare disease-specific trial network ', European Respiratory Journal, vol. 56, no. 3 . https://doi.org/10.1183/13993003.02114-2020
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has disrupted clinical trials worldwide [1]. This could delay the approval of new medicines and reduce access to investigational treatments via clinical trials. This particularly impacts pa
Autor:
Kate Hayes, Fiona Dunlevy, Veerle Bulteel, Damian G. Downey, Anne Verbrugge, S. van Koningsbruggen-Rietschel
Publikováno v:
Journal of Cystic Fibrosis
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has disrupted clinical trials. The European Cystic Fibrosis Society-Clinical Trials Network (ECFS-CTN) tracked disruption to CF trials via regular surveys to adult and paediatric clinics of